Morgan Dempsey Capital Management LLC Has $247,000 Holdings in Kewaunee Scientific Corporation $KEQU

Morgan Dempsey Capital Management LLC boosted its stake in Kewaunee Scientific Corporation (NASDAQ:KEQU) by 41.8% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 4,229 shares of the technology company’s stock after purchasing an additional 1,247 shares during the quarter. Morgan Dempsey Capital Management LLC owned about 0.14% of Kewaunee Scientific worth $247,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of KEQU. Bank of America Corp DE grew its holdings in Kewaunee Scientific by 2,605.9% in the fourth quarter. Bank of America Corp DE now owns 460 shares of the technology company’s stock worth $28,000 after purchasing an additional 443 shares during the period. IFP Advisors Inc grew its holdings in Kewaunee Scientific by 61.5% in the first quarter. IFP Advisors Inc now owns 945 shares of the technology company’s stock worth $37,000 after purchasing an additional 360 shares during the period. American Century Companies Inc. grew its holdings in Kewaunee Scientific by 43.4% in the first quarter. American Century Companies Inc. now owns 49,182 shares of the technology company’s stock worth $1,937,000 after purchasing an additional 14,889 shares during the period. OMERS ADMINISTRATION Corp acquired a new stake in Kewaunee Scientific in the first quarter worth $284,000. Finally, Punch & Associates Investment Management Inc. acquired a new stake in Kewaunee Scientific in the first quarter worth $788,000. 32.69% of the stock is currently owned by institutional investors and hedge funds.

Kewaunee Scientific Stock Up 1.6%

Kewaunee Scientific stock opened at $43.19 on Friday. Kewaunee Scientific Corporation has a 1-year low of $30.33 and a 1-year high of $71.33. The firm has a market capitalization of $123.96 million, a price-to-earnings ratio of 10.46 and a beta of 0.68. The firm’s fifty day moving average price is $49.13 and its two-hundred day moving average price is $45.26. The company has a current ratio of 2.32, a quick ratio of 1.63 and a debt-to-equity ratio of 0.88.

Kewaunee Scientific (NASDAQ:KEQU) last released its quarterly earnings data on Wednesday, September 10th. The technology company reported $1.10 earnings per share for the quarter. Kewaunee Scientific had a net margin of 4.68% and a return on equity of 25.65%. The firm had revenue of $71.10 million for the quarter.

Insider Activity at Kewaunee Scientific

In related news, CFO Donald T. Gardner III sold 3,000 shares of the firm’s stock in a transaction dated Thursday, October 9th. The shares were sold at an average price of $42.76, for a total transaction of $128,280.00. Following the transaction, the chief financial officer directly owned 11,564 shares of the company’s stock, valued at $494,476.64. This trade represents a 20.60% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Thomas David Hull III sold 1,854 shares of the firm’s stock in a transaction dated Monday, September 29th. The shares were sold at an average price of $43.42, for a total transaction of $80,500.68. Following the transaction, the chief executive officer directly owned 39,719 shares in the company, valued at $1,724,598.98. The trade was a 4.46% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 18,880 shares of company stock valued at $865,241 over the last ninety days. Corporate insiders own 13.30% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have commented on KEQU shares. Wall Street Zen upgraded shares of Kewaunee Scientific from a “hold” rating to a “buy” rating in a report on Saturday, July 5th. Weiss Ratings restated a “hold (c+)” rating on shares of Kewaunee Scientific in a report on Wednesday, October 8th. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat, Kewaunee Scientific presently has an average rating of “Hold”.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.